Anatomical Extent of Pelvic Lymphadenectomy in Bladder and Prostate Cancer

Crawford, 2000, The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma, Cancer, 88, 2105, 10.1002/(SICI)1097-0142(20000501)88:9<2105::AID-CNCR16>3.0.CO;2-3 Batuello, 2001, Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer, Urology, 57, 481, 10.1016/S0090-4295(00)01039-6 Partin, 1997, Combination of prostate-specific antigen, clinical stage, and Gleason sum to predict pathological stage of localized prostate cancer: a multi-institutional update, JAMA, 277, 1445, 10.1001/jama.277.18.1445 Bader, 2003, Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a hance of cure?, J Urol, 169, 849, 10.1097/01.ju.0000049032.38743.c7 Heidenreich, 2001, Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy in prostate cancer: high incidence of lymph node metastases, J Urol, 167, 1681, 10.1016/S0022-5347(05)65177-4 Heidenreich A, von Knobloch R, Varga Z, Hofmann R. Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy–data on >300 cases. J Clin Oncol 2004;22(14S) [Proc ASCO, Abstract 4612]. Algari, 1997, The staging pelvic lymphadenectomy: implication as an adjunctive procedure for clinically localized prostate cancer, J Urol, 162, 243, 10.1046/j.1464-410X.1997.00233.x Weingärtner, 1996, Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic, J Urol, 156, 1969, 10.1016/S0022-5347(01)65406-5 Gil-Vernet, 1996, Prostate cancer: anatomical and surgical considerations, Br J Urol, 78, 161, 10.1046/j.1464-410X.1996.00841.x Narayan, 1994, Utility of preoperative serum prostate specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer, Urology, 44, 519, 10.1016/S0090-4295(94)80050-2 Bluestein, 1994, Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer, J Urol, 151, 1315, 10.1016/S0022-5347(17)35239-4 Conrad, 1998, Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastasis in patients with clinically localized prostate cancer, J Urol, 159, 2023, 10.1016/S0022-5347(01)63234-8 Conrad, 2002, Prospective validation of an algorithm with systematic sextant biopsy to predict lymph node metastasis in patients with clinically localized prostate cancer, J Urol, 167, 521, 10.1016/S0022-5347(01)69077-3 Haese, 2002, Validation of a biopsy based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostatic carcinoma, Cancer, 95, 1016, 10.1002/cncr.10811 Naya, 2003, The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy, J Urol, 170, 2306, 10.1097/01.ju.0000097180.98966.06 Schuhmacher, 2004, Lymph nodes metastases in patients with prostate cancer and with a PSA <10ng/ml, Eur Urol Suppl, 3, 17, 10.1016/S1569-9056(04)90059-0 Weckermann, 2005, Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?, Eur Urol, 47, 45, 10.1016/j.eururo.2004.07.017 Dillioglugil, 1997, Risk factors for complications and morbidity after radical retropubic prostatectomy, J Urol, 157, 1760, 10.1016/S0022-5347(01)64856-0 Fergany, 2000, No difference in biochemical failure reates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients, Urology, 56, 92, 10.1016/S0090-4295(00)00550-1 Meng, 2000, When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis, J Urol, 164, 1235, 10.1016/S0022-5347(05)67147-9 El-Galley RES, 1998, Evaluation of staging lymphadenectomy in prostate cancer, Urology, 52, 663, 10.1016/S0090-4295(98)00222-2 Cheng, 2001, Risk of prostate cancer death in patients with lymph node metastasis, Cancer, 91, 66, 10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P Messing EM, Manola J, Sarosdy M, et al. Immediate hormonal therapy versus observation after radical prostatectomy and pelvic lymphadenectomy for node positive prostate cancer: at 10 years results of EST3886. J Clin Oncol 2004;22(14S) [Proc ASCO, Abstract 4570]. Wawroschek, 2001, Radioisotope guided pelvic lymph node dissection for prostate cancer, J Urol, 166, 1715, 10.1016/S0022-5347(05)65659-5 Polasczik, 1999, Comparison of clinical staging algorithms and 111Indium-Capromab Pendetide Immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients, Cancer, 85, 1586, 10.1002/(SICI)1097-0142(19990401)85:7<1586::AID-CNCR21>3.0.CO;2-F Sodee, 2000, Bakale G, and the Prostacint Imaging Centers. Multicenter Prostacint imaging findings in 2154 patients with prostate cancer, Urology, 56, 988, 10.1016/S0090-4295(00)00824-4 Grossmann, 2003, Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer, N Engl J Med, 349, 859, 10.1056/NEJMoa022148 Herr, 2004, Surgical factors influence bladder cancer outcomes: a cooperative group report, J Clin Oncol, 22, 2781, 10.1200/JCO.2004.11.024 Herr, 2004, Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report, J Urol, 171, 1823, 10.1097/01.ju.0000120289.78049.0e Mills, 2001, Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy, J Urol, 166, 19, 10.1016/S0022-5347(05)66067-3 Herr, 2003, Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer, J Urol, 167, 1295, 10.1016/S0022-5347(05)65284-6 Leissner, 2000, Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis, BJU Int, 85, 817, 10.1046/j.1464-410x.2000.00614.x Stein, 2003, Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en-bloc pelvic lymphadenectomy: the concept of lymph node density, J Urol, 170, 35, 10.1097/01.ju.0000072422.69286.0e Abdel-Latif, 2004, Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis, J Urol, 172, 85, 10.1097/01.ju.0000132132.72351.4c Herr, 2003, Superiority of ratio based lymph node staging for bladder cancer, J Urol, 169, 943, 10.1097/01.ju.0000032474.22093.06 Bochner, 2001, Impact of separate versus en bloc lymph node dissection in the number of lymph nodes retrieved in cystectomy specimens, J Urol, 166, 2295, 10.1016/S0022-5347(05)65555-3 Leissner, 2003, Ranking of pelvic lymphadenectomy in therapy and prognosis of carcinoma of the bladder, Akt Urol, 34, 392 Poulsen, 1998, Radical cystectomy: extending limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall, J Urol, 160, 2015, 10.1016/S0022-5347(01)62229-8 Leissner, 2004, Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study, J Urol, 171, 139, 10.1097/01.ju.0000102302.26806.fb Bochner, 2004, Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping, J Urol, 172, 1286, 10.1097/01.ju.0000137817.56888.d1 Abol-Enein, 2004, Lymph node involvement in patients with bladder cancer treated by radical cystectomy: a patho-anatomical study—a single center experience, J Urol, 172, 1818, 10.1097/01.ju.0000140457.83695.a7 Bochner, 2001, Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens, J Urol, 166, 2295, 10.1016/S0022-5347(05)65555-3